These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 31721710)

  • 21. Increased proton-sensing receptor GPR4 signalling promotes colorectal cancer progression by activating the hippo pathway.
    Yu M; Cui R; Huang Y; Luo Y; Qin S; Zhong M
    EBioMedicine; 2019 Oct; 48():264-276. PubMed ID: 31530502
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of G-protein-coupled receptors in mediating the effect of fatty acids on inflammation and insulin sensitivity.
    Oh DY; Lagakos WS
    Curr Opin Clin Nutr Metab Care; 2011 Jul; 14(4):322-7. PubMed ID: 21587066
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Experimental challenges to targeting poorly characterized GPCRs: uncovering the therapeutic potential for free fatty acid receptors.
    Hudson BD; Smith NJ; Milligan G
    Adv Pharmacol; 2011; 62():175-218. PubMed ID: 21907910
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Short-chain free-fatty acid G protein-coupled receptors in colon cancer.
    Moniri NH; Farah Q
    Biochem Pharmacol; 2021 Apr; 186():114483. PubMed ID: 33631190
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Physiology and therapeutics of the free fatty acid receptor GPR40.
    Huang H; Dai MH; Tao YX
    Prog Mol Biol Transl Sci; 2014; 121():67-94. PubMed ID: 24373235
    [TBL] [Abstract][Full Text] [Related]  

  • 26. G protein-coupled receptors for free fatty acids.
    Milligan G; Stoddart LA; Brown AJ
    Cell Signal; 2006 Sep; 18(9):1360-5. PubMed ID: 16716567
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New frontiers in gut nutrient sensor research: free fatty acid sensing in the gastrointestinal tract.
    Miyauchi S; Hirasawa A; Ichimura A; Hara T; Tsujimoto G
    J Pharmacol Sci; 2010; 112(1):19-24. PubMed ID: 20093784
    [TBL] [Abstract][Full Text] [Related]  

  • 28. G2A as a receptor for oxidized free fatty acids.
    Obinata H; Izumi T
    Prostaglandins Other Lipid Mediat; 2009 Sep; 89(3-4):66-72. PubMed ID: 19063986
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The therapeutic potential of allosteric ligands for free fatty acid sensitive GPCRs.
    Hudson BD; Ulven T; Milligan G
    Curr Top Med Chem; 2013; 13(1):14-25. PubMed ID: 23409763
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Free fatty acid receptors and their physiological role in metabolic regulation].
    Hirasawa A; Hara T; Ichimura A; Tsujimoto G
    Yakugaku Zasshi; 2011; 131(12):1683-9. PubMed ID: 22129861
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Free fatty acid (FFA) and hydroxy carboxylic acid (HCA) receptors.
    Offermanns S
    Annu Rev Pharmacol Toxicol; 2014; 54():407-34. PubMed ID: 24160702
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel antidiabetic therapy: free fatty acid receptors as potential drug target.
    Sekiguchi H; Kasubuchi M; Hasegawa S; Pelisch N; Kimura I; Ichimura A
    Curr Diabetes Rev; 2015; 11(2):107-15. PubMed ID: 25732031
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Key Questions for Translation of FFA Receptors: From Pharmacology to Medicines.
    Suckow AT; Briscoe CP
    Handb Exp Pharmacol; 2017; 236():101-131. PubMed ID: 27873087
    [TBL] [Abstract][Full Text] [Related]  

  • 34. G-protein-coupled receptors for free fatty acids: nutritional and therapeutic targets.
    Milligan G; Ulven T; Murdoch H; Hudson BD
    Br J Nutr; 2014 Jun; 111 Suppl 1():S3-7. PubMed ID: 24382058
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Free fatty acid receptor family: novel targets for the treatment of diabetes and dyslipidemia.
    Bernard J
    Curr Opin Investig Drugs; 2008 Oct; 9(10):1078-83. PubMed ID: 18821469
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dietary Supplementation of Foxtail Millet Ameliorates Colitis-Associated Colorectal Cancer in Mice via Activation of Gut Receptors and Suppression of the STAT3 Pathway.
    Zhang B; Xu Y; Liu S; Lv H; Hu Y; Wang Y; Li Z; Wang J; Ji X; Ma H; Wang X; Wang S
    Nutrients; 2020 Aug; 12(8):. PubMed ID: 32784751
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of 9-hydroxyoctadecadienoic acid and other oxidized free fatty acids as ligands of the G protein-coupled receptor G2A.
    Obinata H; Hattori T; Nakane S; Tatei K; Izumi T
    J Biol Chem; 2005 Dec; 280(49):40676-83. PubMed ID: 16236715
    [TBL] [Abstract][Full Text] [Related]  

  • 38. G-protein-coupled receptors mediate ω-3 PUFAs-inhibited colorectal cancer by activating the Hippo pathway.
    Zhang K; Hu Z; Qi H; Shi Z; Chang Y; Yao Q; Cui H; Zheng L; Han Y; Han X; Zhang Z; Chen T; Hong W
    Oncotarget; 2016 Sep; 7(36):58315-58330. PubMed ID: 27506947
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Free fatty acid receptor GPR120 and pathogenesis of obesity and type 2 diabetes mellitus.
    Mo XL; Wei HK; Peng J; Tao YX
    Prog Mol Biol Transl Sci; 2013; 114():251-76. PubMed ID: 23317787
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Co-expression of Lgr5 and CXCR4 characterizes cancer stem-like cells of colorectal cancer.
    Wu W; Cao J; Ji Z; Wang J; Jiang T; Ding H
    Oncotarget; 2016 Dec; 7(49):81144-81155. PubMed ID: 27835894
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.